What Is Canine BPH?
Benign prostatic hyperplasia (BPH) is a gradual, testosterone-dependent (specifically DHT, dihydrotestosterone) enlargement of the prostate. It is the most common prostatic condition in dogs β affecting 80 % of intact males by age 5 and virtually 100 % by age 10. Unlike prostate cancer, it is benign and treatable.
Symptoms
- Faecal tenesmus: straining to defecate, ribbon-shaped stools (the enlarged prostate compresses the rectum).
- Haematuria or haemospermia: blood in urine or semen, sometimes blood-tinged prepucial discharge.
- Dysuria: straining to urinate, weak or dribbling urinary stream.
- Prepucial discharge: clear or slightly blood-tinged prostatic fluid.
- In complications (prostatitis, cysts, abscesses): fever, abdominal pain, stiff hind-limb gait.
Diagnosis
- Ultrasound: technique of choice β assesses size, echogenicity, cysts and focal lesions.
- Abdominal X-ray: shows prostatic enlargement displacing bladder or colon.
- Urinalysis + culture: rules out secondary urinary infection.
- Rectal examination: direct palpation of the prostate (size, consistency, pain).
Treatment
Surgical castration: the definitive and most effective treatment:
- 50 % reduction in prostate size within 3 weeks.
- 70 % reduction within 3 months.
- Resolution of symptoms in the vast majority of cases.
Medical alternatives (when surgery is not possible):
- Deslorelin implant (GnRH agonist): reversible hormonal suppression. Effect similar to castration, lasts 6-12 months.
- Finasteride: inhibits testosterone-to-DHT conversion. Reduces prostatic volume in 4-6 weeks.
